| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -4.13 | -3.86 | -3.85 | -3.51 |
| Net Changein Cash | 30.57 | 5.23 | 51.92 | 96.08 |
| Cash Taxes Paid | 64.19 | 56.43 | 40.82 | 24.79 |
| Net Income/ Starting Line | 156.36 | 219.54 | 134.10 | 83.04 |
| Total Cash Dividends Paid | -60.00 | -40.00 | -20.00 | -5.00 |
| Changesin Working Capital | -167.41 | -184.60 | -71.01 | 8.10 |
| Cashfrom Operating Activities | 65.36 | 27.87 | 58.29 | 100.80 |
| Cash Interest Paid | 1.46 | 0.52 | 0.63 | 0.95 |
| Cashfrom Financing Activities | -65.59 | -44.38 | -24.48 | -9.46 |
| Depreciation/ Depletion | 39.99 | 14.94 | 16.26 | 16.95 |
| Other Investing Cash Flow Items Total | 32.55 | 32.50 | 26.63 | 14.36 |
| Capital Expenditures | -1.75 | -10.76 | -8.52 | -9.62 |
| period Type | - | - | - | - |
| Non- Cash Items | 36.42 | -22.01 | -21.06 | -7.29 |
| Financing Cash Flow Items | -1.46 | -0.52 | -0.63 | -0.95 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | 30.80 | 21.74 | 18.11 | 4.74 |
AstraZeneca Pharma India Ltd Dividend AstraZeneca Pharma India Ltd Bonus AstraZeneca Pharma India Ltd News AstraZeneca Pharma India Ltd AGM AstraZeneca Pharma India Ltd Rights AstraZeneca Pharma India Ltd Splits AstraZeneca Pharma India Ltd Board Meetings AstraZeneca Pharma India Ltd Key Metrics AstraZeneca Pharma India Ltd Shareholdings AstraZeneca Pharma India Ltd Profit Loss AstraZeneca Pharma India Ltd Balance Sheet AstraZeneca Pharma India Ltd Q1 Results AstraZeneca Pharma India Ltd Q2 Results AstraZeneca Pharma India Ltd Q3 Results AstraZeneca Pharma India Ltd Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks